-transparent.png){kind=logo}
Systemic lupus erythematosus (SLE), a connective tissue disease characterized by the production of autoantibodies, can affect all organ systems. Cardiac involvement in patients with SLE has been described since the early 20th century. The manifestations are numerous and can involve all components of the heart, including the pericardium, conduction system, myocardium, valves, and coronary arteries. In recent years, echocardiography has yielded additional information about the heart in patients who have SLE with and without clinical cardiac involvement. Moreover, antiphospholipid antibodies have been linked to several cardiac manifestations in patients with SLE, including valvular abnormalities and possibly coronary artery disease. This updated, comprehensive review summarizes the new literature on SLE and the heart.
K G Moder, and
T D Miller, and
H D Tazelaar
January 2005,
Lupus,
K G Moder, and
T D Miller, and
H D Tazelaar
January 1997,
Likars'ka sprava,
K G Moder, and
T D Miller, and
H D Tazelaar
February 1991,
Harefuah,
K G Moder, and
T D Miller, and
H D Tazelaar
March 1995,
The West Indian medical journal,
K G Moder, and
T D Miller, and
H D Tazelaar
January 1976,
Revista medica de Chile,
K G Moder, and
T D Miller, and
H D Tazelaar
March 2002,
Polskie Archiwum Medycyny Wewnetrznej,
K G Moder, and
T D Miller, and
H D Tazelaar
January 1993,
Revista da Associacao Medica Brasileira (1992),
K G Moder, and
T D Miller, and
H D Tazelaar
May 1990,
The American journal of cardiology,
K G Moder, and
T D Miller, and
H D Tazelaar
February 2019,
La Tunisie medicale,
K G Moder, and
T D Miller, and
H D Tazelaar
October 1964,
Sovetskaia meditsina,
